InvestorsHub Logo
Followers 58
Posts 10154
Boards Moderated 1
Alias Born 09/21/2016

Re: nidan7500 post# 145040

Monday, 03/19/2018 11:51:59 AM

Monday, March 19, 2018 11:51:59 AM

Post# of 462572
https://www.bizjournals.com/boston/news/2018/03/14/shares-of-solid-biosciences-crater-as-fda-halts.html?ana=yahoo&yptr=yahoo...

Example of what is to be a new hurdle for IND...see text near last para as "Clinical Hold". Caused this stock to drop last week.

It all fits If one considers new trials are based on precision medicine then we should expect a much higher bar for IND-NDA. So, the back and forth w/FDA mentioned for A2-73 RETT is more than likely the new way forward. IMO, We are about where we should be as it is clear the FDA are REALLY tuned in here on making this process work.BTW this new regulatory model was effective (2/18) about the time we were at threshold.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News